CBS 2019
CBSMD教育中心
English

DAPT Duration

科研文章

荐读文献

Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial Dual antiplatelet therapy (PEGASUS) vs. dual pathway (COMPASS): a head-to-head in vitro comparison Ticagrelor versus clopidogrel in patients with acute coronary syndromes Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor 'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study

Original Research2019 Feb 21. [Epub ahead of print]

JOURNAL:Catheter Cardiovasc Interv. Article Link

Novel predictors of late lumen enlargement in distal reference segments after successful recanalization of coronary chronic total occlusion

Okuya Y, Saito Y, Takahashi T et al. Keywords: chronic total occlusion; coronary intervention; vessel enlargement

ABSTRACT


OBJECTIVES - Although successful recanalization of coronary chronic total occlusion (CTO) can induce subsequent positive vascular remodeling in the distal segment, the predictors are not fully understood. The aim of this study was to investigate the extent and predictors related to luminal gain after successful CTO recanalization.


METHODS - A total of 134 patients who underwent intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) for CTO and follow-up angiography were included. Angiographic parameters were assessed qualitatively and quantitatively at baseline and follow-up. Gray-scale IVUS images during the PCI procedure were also analyzed. Lumen diameter (LD) at distal reference on the post-PCI angiogram was compared with corresponding LD at follow-up coronary angiography.


RESULTS - At the mean follow-up of 10.0 ± 2.7 months, LD at distal reference was significantly increased by 15.9% from baseline to follow-up (2.06 ± 0.62 vs. 2.30 ± 0.55 mm, p < 0.001). Univariable analysis indicated that the left anterior descending artery (LAD), no moderate or severe calcification, presence of peri-medial high-echoic band on IVUS, and impairment of final coronary flow and small distal reference diameter at baseline were associated with greater late lumen enlargement. Multivariable analysis showed the LAD, no moderate or severe calcification, and small LD at distal reference as independent predictors of greater late lumen enlargement.


CONCLUSION - The segment distal to recanalized CTO showed significant late lumen enlargement, especially in the cases with small distal reference, in the LAD, and without moderate or severe calcification.

 

© 2019 Wiley Periodicals, Inc.